Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dymicron is a medical device company that develops high-performance orthopedic implants using proprietary synthetic diamond technology. Based in Orem, Utah, the company utilizes Polycrystalline Diamond (PCD) to create joint replacement components with exceptional durability and minimal wear. Their lead product, the Triadome® Cervical Total Disc Replacement, features a unique tri-lobe design that emulates natural spinal kinematics. By leveraging the hardness and biocompatibility of diamond, Dymicron aims to provide long-lasting solutions for patients suffering from degenerative disc disease. The company's technology platform has potential applications across various orthopedic and medical fields where friction and wear are critical factors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dimicron.